Biogen Inc. buy BMO Capital Markets
Start price
26.07.23
/
50%
€243.00
Target price
26.07.24
€313.55
Performance (%)
-19.94%
End price
27.07.24
€194.55
Summary
This prediction ended on 27.07.24 with a price of €194.55. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.94%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | -2.268% | -2.268% | 60.181% | -29.328% |
| iShares Core DAX® | 0.184% | 5.072% | 8.979% | 63.879% |
| iShares Nasdaq 100 | -0.770% | -2.079% | 26.437% | 88.094% |
| iShares Nikkei 225® | 0.733% | -3.346% | 47.887% | 78.014% |
| iShares S&P 500 | -0.166% | 0.904% | 22.974% | 69.449% |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $357.00 to $347.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten